Animal Biosafety Level 2 (ABSL-2): Requirements and the BSL-2 Deltas

Animal Biosafety Level 2 (ABSL-2) is the containment tier for laboratory animal work involving agents that pose a moderate hazard to personnel and the environment, including exposure by ingestion and by percutaneous or mucous-membrane contact, not aerosol alone. It builds on ABSL-1, and the two most common mistakes with it are treating it as identical to laboratory BSL-2, and treating "BSL-2+" institutional shorthand as if it were the same concept as ABSL-2. It is not: ABSL-2 is a formally defined tier in the CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th edition (2020), Section V; BSL-2+ has no equivalent anchor in BMBL at all, and applies to bench laboratories, not vivaria. This guide works from BMBL Section V’s actual ABSL-2 criteria — standard and special practices, safety equipment, and facility requirements — and then sets out specifically where ABSL-2 adds requirements that laboratory BSL-2 does not have.

The review gate: IACUC and IBC, not IACUC alone

Before an ABSL-2 study can begin, BMBL’s Standard Practice A.3 requires that the animal protocol is reviewed and approved by both the Institutional Animal Care and Use Committee (IACUC) and the Institutional Biosafety Committee (IBC), or an equivalent body. A protocol that clears IACUC on animal-welfare grounds but skips IBC biosafety review is not ABSL-2 compliant, and vice versa — the two reviews cover different risk categories (animal welfare and husbandry versus infectious-agent containment) and neither substitutes for the other. This dual-review requirement is a real, frequent gap: research teams that have only ever worked with uninfected animals under IACUC alone often don’t build in the IBC step the first time a protocol introduces an infectious agent.

Standard microbiological practices

• Facility governance. The animal facility director establishes and enforces biosafety, biosecurity, and emergency policies; access to the animal room is limited to personnel required for experimental, husbandry, or support purposes.
• Training and records. Personnel receive training on husbandry procedures, agent-specific hazards, and exposure-evaluation procedures, with annual updates and records retained for hazard evaluations and training sessions. Visitors, service workers, and facility-equipment personnel are also advised of potential hazards before entry.
• Occupational health. An animal-allergy prevention program is part of medical surveillance, and personnel using respirators for allergy protection are enrolled in a formal respiratory-protection program — this is one of the clearest places ABSL-2 diverges from bench BSL-2 (see the list below).
• Signage. A sign at the animal-room entrance shows the biohazard symbol, the room’s Animal Biosafety Level, the responsible person’s name and phone number, PPE requirements, occupational health requirements, and entry/exit procedures.
• Sharps and glove discipline. Mouth pipetting is prohibited; needle use is limited to situations with no alternative and needles are never recapped, bent, or removed from syringes by hand; glove selection follows a risk assessment (bite- or scratch-resistant gloves are considered), gloves worn inside the facility are never worn outside it, and used disposable gloves are discarded with other contaminated animal-facility waste, never reused.
• Decontamination before disposal. All cultures, stocks, and other potentially infectious materials are decontaminated by an effective, institutionally-consistent method before disposal or transport; materials leaving the animal room for decontamination elsewhere go in a durable, leak-proof, labeled container.
• Integrated pest management. An effective IPM program is required (BMBL Appendix G) — a requirement with no direct bench-BSL-2 counterpart, since it addresses vermin access to animal bedding and feed.

Special practices

All manipulation of infectious materials capable of generating an aerosol is performed inside a biosafety cabinet (BSC) or other physical containment device where possible; where it isn’t possible, a risk-assessed combination of PPE and engineering/administrative controls (for example, a downdraft table) is used instead. Cages are handled to minimize contamination of other areas and are decontaminated before washing, not just cleaned. Institutions develop and implement a formal decontamination program covering routine equipment, sensitive electronic/medical equipment, and whole-room decontamination triggers (gross contamination, major renovation, or a change in room use).

Safety equipment: caging, PPE, and BSCs

Where a risk assessment calls for it, animals are housed in solid wall and bottom cages covered with micro-isolator lids, or an equivalent primary containment system for larger animals. If actively ventilated caging (IVC) is used instead, BMBL requires the exhaust plenums to be sealed, a safety mechanism to prevent the cage and plenum from going positive if the exhaust fan fails, an alarm on malfunction, and annual certification of the exhaust HEPA filters and housings.

Protective clothing (gowns, uniforms, or scrubs) is worn throughout the animal areas and removed before leaving the facility; reusable clothing is decontaminated before laundering and animal-facility clothing is never taken home. Eye and face protection is required for any manipulation outside a BSC that could splash or spray, and disposable PPE is decontaminated or contained before disposal, not thrown in general waste.

Facility requirements (secondary barriers)

• Separated from general building traffic patterns, with self-closing and self-locking external doors, and doors to animal/infectious-material areas that open inward, self-close, and are never propped open.
• A handwashing sink at the exit of every area where infectious materials or animals are housed or manipulated, plus emergency eyewash and shower.
• Directional airflow into the facility (inward relative to adjoining hallways), with a ducted exhaust system that discharges outside and is never recirculated to other rooms.
• Mechanical cage washers with a final rinse temperature of at least 180°F, in a cage-wash area designed for high-pressure spray, humidity, and strong disinfectants at that temperature.
• BSCs installed away from doors, openable windows, and high-traffic areas, and certified at least annually.
• An autoclave present in the animal facility itself, to decontaminate infectious materials and waste, with a validated alternative — alkaline digestion or incineration — permitted specifically for carcass decontamination and disposal.

Where ABSL-2 actually adds to BSL-2, not just repeats it

The BSL-2-plus-animals framing undersells how much ABSL-2 adds. Reading BMBL Section V’s ABSL-2 criteria against the laboratory BSL-2 criteria in the same edition, five requirements are genuinely animal-specific with no bench-BSL-2 equivalent:

1. An onsite autoclave is a stated hard facility requirement for ABSL-2, not a "preferably" recommendation the way BMBL phrases waste decontamination access for laboratory BSL-3.
2. Cage decontamination and mechanical cage-wash temperature specs (180°F final rinse) have no bench equivalent at all.
3. Actively ventilated caging engineering controls — sealed exhaust plenums, anti-positive-pressurization safeguards, alarmed malfunction detection, annual HEPA certification — are unique to housing live animals.
4. A formal animal-allergy occupational health program, including a respiratory-protection program for staff using respirators for allergy protection, has no equivalent in bench BSL-2’s occupational-health language.
5. The added IACUC review, on top of IBC, is unique to animal work; bench BSL-2 requires IBC review of the biosafety plan but has no IACUC step because there is no animal-welfare dimension.

For where Risk Group and Biosafety Level are not interchangeable more generally — a related and frequently conflated distinction — see CASRAI’s Biosafety Levels BSL-1 to BSL-4 guide, which also covers BMBL’s six-step risk-assessment process. For the review-body split itself, see IACUC vs. IBC.

Frequently asked

Does ABSL-2 always require a dedicated vivarium room, or can it be a shared space?

BMBL requires ABSL-2 areas to be separated from general traffic patterns and access-restricted, with self-closing doors and inward airflow relative to adjoining hallways — in practice this usually means a dedicated animal room rather than a shared general-purpose lab space, though the exact configuration is a facility-level risk assessment, not a single fixed floor plan BMBL prescribes.

Is an in-room autoclave mandatory, or can decontamination happen elsewhere in the building?

BMBL states an autoclave is present in the animal facility to decontaminate infectious materials and waste, with a validated alternative (alkaline digestion or incineration) specifically for carcasses — this is a facility-level requirement for ABSL-2, distinct from the more flexible "preferably within the laboratory" phrasing BMBL uses for BSL-3 laboratory waste decontamination.

Who signs off before an ABSL-2 study starts?

Both the IACUC and the IBC (or an institutional equivalent) review and approve the protocol before work begins — not one committee acting alone.

Sources

CDC/NIH, Biosafety in Microbiological and Biomedical Laboratories, 6th edition (2020), Section V (Vertebrate Animal Biosafety Level Criteria for Vivarium Research Facilities), Animal Biosafety Level 2. This is an advisory document, not a standalone regulation, but is incorporated by reference into the NIH Guidelines and Federal Select Agent Program frameworks.